학술논문
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial
Document Type
Article
Author
Source
In: The Lancet Rheumatology . (The Lancet Rheumatology, January 2024, 6(1):e40-e50)
Subject
Language
English
ISSN
26659913